Due to logistic issues, mRNA vaccines hasn’t reached to the neediest one. The pricing of the vaccine hasn’t been decided yet, it’s under conversation with the govt but it has to be competitive pricing: Sanjay Singh, CEO, Gennova Biopharmaceuticals Ltd, on India’s 1st mRNA vaccine pic.twitter.com/Df0vAF0pcD— ANI (@ANI) June 29, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


